Filter Results:
(5,160)
Show Results For
- All HBS Web
(5,160)
- People (17)
- News (2,028)
- Research (2,487)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,841)
Show Results For
- All HBS Web
(5,160)
- People (17)
- News (2,028)
- Research (2,487)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,841)
- 10 Nov 2003
- Research & Ideas
A Fast Start on Your New Job
distinct subcultures. This is all the more dangerous because the new leader is not expecting there to be these differences. Also, as you rise in an organization, the politics become more complicated and the stakes get higher. I advise new leaders to View Details
Keywords: by Martha Lagace
- 01 Sep 2008
- News
Business Plan Contest Winners
The 12th annual HBS Business Plan Contest winner in the social enterprise track was Diagnostics-For-All (DFA), a nonprofit launched to develop a disposable, low-cost, paper-based “lab-on-a-chip” for use in diagnosing liver, kidney, and metabolic diseases in the world’s... View Details
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
- 08 Jun 2010
- First Look
First Look: June 8
model for inflammatory bowel disease in 2001 and 2009, before and after the reorganization. The case can be used to examine health care provider strategy, integrated care... View Details
Keywords: Martha Lagace
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 11 Jul 2017
- First Look
First Look at New Ideas and Research, July 11
customers, and (4) becoming a supplier to a multisided platform. These ideas can be used by physical as well as online businesses. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52837 forthcoming The Laryngoscope Time-Driven Activity-Based Costing to... View Details
Keywords: Sean Silverthorne
- 29 Sep 2003
- Research & Ideas
Pride Goeth Before a Profit
to employees' identity and self-worth. Caring About Accuracy Dave Thompson was appointed a measurement technician at El Segundo, CA-based Unocal's Van, TX, oil field in 1993. He was responsible for making sure that the amounts of oil and... View Details
Keywords: by Theodore Kinni
- 08 Dec 2008
- Research & Ideas
Thinking Twice About Supply-Chain Layoffs
manager changes his or her hours, it can upset a delicate balance of work schedules, family commitments, and child care, which in turn can derail increasingly fragile family budgets. In a survey of Wal-Mart employees, for instance, scheduling even beat out View Details
- 01 Sep 2010
- News
Noted & Quoted
“If I had been leaving Harvard in 2010, this would be the area I would want to be going into.” — Sir Ronald Cohen (MBA ’69), a founder of the European venture capital industry, referring to his latest venture, Social Finance, a social investment bank. (London... View Details
- 31 Mar 2009
- First Look
First Look: March 31, 2009
PublicationsInnovator's Prescription: A Disruptive Solution for Health Care Authors:Clayton M. Christensen, Jerome H. Grossman M.D., and Jason Hwang M.D. Publication:McGraw-Hill, 2009 Abstract A... View Details
Keywords: Martha Lagace
- 01 Mar 2007
- News
Avon CEO Jung on Leadership
Jung Andrea Jung, chairman and CEO of Avon Products, Inc., knows a thing or two about reinvention. After taking over the venerable beauty-products firm in 1999, she helped it shed the last vestiges of its “Ding-dong, Avon calling” image and morph into a glamorous... View Details
- Career Coach
Ben Schlatka
Ben (HBS '05) has deep experience in technology driven organizations - including fund raising and venture formation, product marketing, product management, business development and managing technical professionals in large public and small venture funded technology... View Details
Keywords: Health Care; Health Care; Health Care; Health Care; Health Care; Health Care; Health Care; Health Care
- 01 Sep 2022
- News
Your Family, Your Work, Your Way
do with so many of my clients is sit down with this special tool that I call Eight C. Each of the different Cs is just a different category or type of health and support that you might be able to get as a working parent, that would be... View Details
- 01 Dec 2001
- News
Reaching Out
"Many people want to spend their productive years doing something that they care about, and one way to do that is to work through the social sector on issues that markets alone don't always address,"... View Details
- 19 Nov 2010
- Research & Ideas
The Landscape of Integrated Reporting: An E-Book
lost trust in business. Whether it be the environment, health care, or making sure that people have access to information, I can't think of any major problem that society confronts today that can be effectively solved unless business... View Details
- 01 Jun 2023
- News
Action Plan: Net Proceeds
“I’m a root-cause kind of guy,” says Robert Goodwin (GMP 3, 2007), reflecting on a military, government, and civilian career that has taken him from counterdrug operations in Colombia to assisting with the peace process in Sudan to rebuilding the health care system in... View Details
- 04 Oct 2017
- Blog Post
What Should German Applicants Know about HBS?
Before attending HBS, German native Charlotte Pallua spent three years at The Boston Consulting Group in Munich where she worked on a variety of health care related projects in Tokyo, London, Miami, and... View Details
- 19 May 2016
- Blog Post
5 Lessons from Business School
provide time to expand your view and explore new passions. For example, I have been able to explore my interest in health care and learn a lot more about the industry than I had time for while working. I... View Details
- 01 Feb 2002
- News
Web Exclusive: Behind the Scenes with Karen Tumulty
scoop: Naomi Wolf and the alpha male The Better Half 12/28/98 Hillary Clinton shines as husband declines Let's Play Doctor 7/13/98 Politicians and health care Why Subsidies Survive 3/25/96 Congress and... View Details
- 2024
- Working Paper
Prozac—Controversial Blockbuster: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes the development of Prozac, a blockbuster drug that transformed
the treatment of depression – and became a cultural phenomenon in the United States. Specifically, we
chronicle the: 1) prior treatments for depression and the research that... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Prozac—Controversial Blockbuster: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-135, July 2020. (Revised May 2024.)